Paper17517847
In vitro interactions between apricitabine and other deoxycytidine analogues.
Bethell R and 6 others. Antimicrob Agents Chemother, 2007. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. In vitro interactions between apricitabine and other deoxycytidine analogues. Papers, record 17517847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17517847
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Deoxycytidine | Major topic |
| HIV-1 | Major topic |
| Leukocytes, Mononuclear | Major topic |
| Reverse Transcriptase Inhibitors | Major topic |
| Drug Interactions | |
| Emtricitabine | |
| HIV Reverse Transcriptase | |
| Humans | |
| Lamivudine | |
| Male | |
| Microbial Sensitivity Tests |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10882616 | In vivo antagonism with zidovudine plus stavudine combination therapy. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10882616 | PubMed |
| 2 | 17242147 | Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17242147 | PubMed |
| 3 | 12019083 | Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12019083 | PubMed |
| 4 | 12462795 | HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice. | Acta Clin Belg | 2002 | https://conductscience.org/library/papers/12462795 | PubMed |
| 5 | 12543687 | Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12543687 | PubMed |
| 6 | 12790515 | Cellular pharmacology of D-d4FC, a nucleoside analogue active against drug-resistant HIV. | Antivir Chem Chemother | 2003 | https://conductscience.org/library/papers/12790515 | PubMed |
| 7 | 14693537 | Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14693537 | PubMed |
| 8 | 15012649 | Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). | HIV Med | 2004 | https://conductscience.org/library/papers/15012649 | PubMed |
| 9 | 2430286 | Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/2430286 | PubMed |
| 10 | 2764535 | Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2764535 | PubMed |
| 11 | 8175673 | Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8175673 | PubMed |
| 12 | 8769637 | Intracellular metabolism of zidovudine and stavudine in combination. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8769637 | PubMed |
| 13 | 9174176 | Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174176 | PubMed |
| 14 | 9337075 | Lamivudine (3TC) phosphorylation and drug interactions in vitro. | Biochem Pharmacol | 1997 | https://conductscience.org/library/papers/9337075 | PubMed |
| 15 | 10428900 | Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10428900 | PubMed |
| 16 | 16092505 | Intracellular interactions between nucleos(t)ide inhibitors of HIV reverse transcriptase. | AIDS Rev | 2005 | https://conductscience.org/library/papers/16092505 | PubMed |
| 17 | 16245645 | In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs. | Antivir Chem Chemother | 2005 | https://conductscience.org/library/papers/16245645 | PubMed |
| 18 | 16436719 | In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16436719 | PubMed |
| 19 | 16816554 | Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients. | AIDS | 2006 | https://conductscience.org/library/papers/16816554 | PubMed |
| 20 | 11227992 | Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro. | Antivir Chem Chemother | 2000 | https://conductscience.org/library/papers/11227992 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27353267 | Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27353267 | PubMed |
| 23554824 | Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors. | Drug Discov Today Technol | 2012 | https://conductscience.org/library/papers/23554824 | PubMed |
| 22778958 | HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions. | Mol Biol Int | 2012 | https://conductscience.org/library/papers/22778958 | PubMed |
| 21470681 | Global gene expression and Ingenuity biological functions analysis on PCBs 153 and 138 induced human PBMC in vitro reveals differential mode(s) of action in developing toxicities. | Environ Int | 2011 | https://conductscience.org/library/papers/21470681 | PubMed |
| 21118913 | Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. | J Antimicrob Chemother | 2011 | https://conductscience.org/library/papers/21118913 | PubMed |
| 17242147 | Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17242147 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DCK | 1633 | PubTator's text mining | https://conductscience.org/library/genes/1633 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17517847
GET https://conductscience.org/api/papers/v1/17517847/authors